Torasemide extended release - Sarfez PharmaceuticalsAlternative Names: Torsemide extended release - Sarfez Pharmaceuticals
Latest Information Update: 19 Nov 2013
At a glance
- Originator Sarfez Pharmaceuticals
- Class Antihypertensives; Heart failure therapies; Small molecules; Sulfonamides
- Mechanism of Action Loop diuretics; Sodium-potassium-chloride symporter inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Oedema